A detailed history of Leavell Investment Management, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Leavell Investment Management, Inc. holds 3,493 shares of NVO stock, worth $366,974. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,493
Previous 3,485 0.23%
Holding current value
$366,974
Previous $497,000 16.5%
% of portfolio
0.02%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$119.07 - $145.42 $952 - $1,163
8 Added 0.23%
3,493 $415,000
Q2 2024

Jul 17, 2024

BUY
$122.71 - $146.91 $203,944 - $244,164
1,662 Added 91.17%
3,485 $497,000
Q1 2024

Apr 24, 2024

BUY
$102.11 - $135.92 $186,146 - $247,782
1,823 New
1,823 $234,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Leavell Investment Management, Inc. Portfolio

Follow Leavell Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Leavell Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Leavell Investment Management, Inc. with notifications on news.